Dapagliflozin Prescribing at ROYAL CRESCENT SURGERY
Drugs used in diabetes | Endocrine System
Items (12m)
799
Total Quantity
16.6K
NHS Cost
£20.6K
vs National Avg
-36.2%
ROYAL CRESCENT SURGERY prescribed 799 items of Dapagliflozin over the last 12 months at a cost of £20,607 to the NHS. This is 36.2% below the national average prescribing rate. Dapagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
76
Jul 2026
59
Jul 2026
61
Jul 2026
60
Jul 2026
56
Jul 2026
68
Jul 2026
67
Jul 2026
52
Jul 2026
76
Jul 2026
69
Jul 2026
73
Jul 2026
82
Prescribing Details
| Total Items | 799 |
|---|---|
| Total Quantity | 16,555 |
| Total NHS Cost | £20,607 |
| Presentations | 2 different forms |
| vs National Average | -36.2% |
Dapagliflozin Prescribing Comparison
| This practice | 799 items |
|---|---|
| National average per practice | 1,252 items |
| Difference | -36.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.